Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 21.5% | 14.7% | 14.2% | 11.4% | 12.0% | 11.8% | 14.3% | 16.0% | 16.7% | 16.8% | 16.9% | 18.3% | 20.4% | 24.1% | 32.4% | 31.7% | 39.8% | 44.2% | 31.6% | 34.9% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is 38.6%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual ROIC - WACC for IDEXX Laboratories, Inc. have been 33.8% over the past three years, and 35.1% over the past five years.
As of today, IDEXX Laboratories, Inc.'s ROIC - WACC is 38.6%, which is higher than industry median of (41.6%). It indicates that IDEXX Laboratories, Inc.'s ROIC - WACC is Good.